PL328790A1 - T-lymphocytes provoking an immunological response and methods of using them - Google Patents

T-lymphocytes provoking an immunological response and methods of using them

Info

Publication number
PL328790A1
PL328790A1 PL97328790A PL32879097A PL328790A1 PL 328790 A1 PL328790 A1 PL 328790A1 PL 97328790 A PL97328790 A PL 97328790A PL 32879097 A PL32879097 A PL 32879097A PL 328790 A1 PL328790 A1 PL 328790A1
Authority
PL
Poland
Prior art keywords
provoking
lymphocytes
methods
immunological response
immunological
Prior art date
Application number
PL97328790A
Other languages
English (en)
Inventor
David Berd
Giorgio Parmiani
Andrea Anichini
Marialuiza Sensi
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Publication of PL328790A1 publication Critical patent/PL328790A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/32—T-cell receptors [TCR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4271—Melanoma antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL97328790A 1996-10-04 1997-10-02 T-lymphocytes provoking an immunological response and methods of using them PL328790A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2700296P 1996-10-04 1996-10-04

Publications (1)

Publication Number Publication Date
PL328790A1 true PL328790A1 (en) 1999-02-15

Family

ID=21835095

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328790A PL328790A1 (en) 1996-10-04 1997-10-02 T-lymphocytes provoking an immunological response and methods of using them

Country Status (7)

Country Link
EP (1) EP0871480A4 (fr)
AU (1) AU4976697A (fr)
CA (1) CA2242590A1 (fr)
IL (1) IL125747A0 (fr)
NZ (1) NZ330995A (fr)
PL (1) PL328790A1 (fr)
WO (1) WO1998014206A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3482199A (en) * 1998-04-09 1999-11-01 Thomas Jefferson University A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
JP2002513772A (ja) * 1998-05-04 2002-05-14 トーマス・ジェファーソン・ユニバーシティ 腫瘍細胞および抽出物を含む組成物、ならびにそれらの使用方法
AU757980B2 (en) 1999-03-16 2003-03-13 Thomas Jefferson University Hapten-conjugated mammalian cells and methods of making and using thereof
US7297330B2 (en) * 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
JP2005528901A (ja) 2002-06-10 2005-09-29 アバクス・テクノロジーズ・インコーポレーテッド ハプテン化腫瘍細胞の凍結保存
WO2005059179A1 (fr) * 2003-12-12 2005-06-30 Bayer Pharmaceutical Corporation Procede de prediction et de pronostic du cancer, et surveillance de traitement anticancereux
US12247060B2 (en) 2018-01-09 2025-03-11 Marengo Therapeutics, Inc. Calreticulin binding constructs and engineered T cells for the treatment of diseases
JP7554742B2 (ja) 2018-07-03 2024-09-20 マレンゴ・セラピューティクス，インコーポレーテッド 抗ｔｃｒ抗体分子およびその使用
EP3906057A4 (fr) * 2019-01-04 2022-09-14 Marengo Therapeutics, Inc. Molécules d'anticorps anti-tcr et leurs utilisations
GB2597851B (en) 2019-02-21 2024-05-29 Marengo Therapeutics Inc Antibody molecules that bind to NKP30 and uses thereof
AU2020226893B2 (en) 2019-02-21 2025-02-27 Marengo Therapeutics, Inc. Multifunctional molecules that bind to T cell related cancer cells and uses thereof
GB2609554B (en) 2020-01-03 2025-08-20 Marengo Therapeutics Inc Anti-TCR antibody molecules and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
DE69533295T3 (de) * 1994-02-16 2009-07-16 The Government Of The United States Of America, As Represented By The Secretary, The Department Of Health And Human Services Melanoma-assoziierte Antigene, Epitope davon und Impstoffe gegen Melanoma
IL122455A0 (en) * 1995-06-07 1998-06-15 Univ Jefferson Hapten modified tumor cell extract and methods of treating or screening for cancer

Also Published As

Publication number Publication date
IL125747A0 (en) 1999-04-11
EP0871480A4 (fr) 2001-04-04
AU4976697A (en) 1998-04-24
WO1998014206A1 (fr) 1998-04-09
NZ330995A (en) 2000-12-22
CA2242590A1 (fr) 1998-04-09
EP0871480A1 (fr) 1998-10-21

Similar Documents

Publication Publication Date Title
AU4954397A (en) Multifunctional microstructures and preparation thereof
GB2326841B (en) Combined thermal and acoustic insulator
GB2307786A9 (en) An assembly of an optical component and an opticalwaveguide
AU5752398A (en) Novel ketobenzamides and their use
AU4997397A (en) Card-recognition and gaming-control device
AU3889897A (en) Acoustic heterodyne device and method
AU1762797A (en) Insulated wall and components therefor
AU3075197A (en) Novel methods of o-demethylation and n-deprotection
AU6108798A (en) Telecommunications arrangements and methods
EP0923313A4 (fr) Riz a cuisson rapide ou instantanee et procede de fabrication
AU5843898A (en) Receiving device and signal receiving method
AU2572797A (en) Adam proteins and uses thereof
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
PL328790A1 (en) T-lymphocytes provoking an immunological response and methods of using them
AU5175798A (en) Membrane and methods of preparing and using same
AU1694097A (en) Novel ceramic igniter and method of using same
AU5044898A (en) Glycolipid mimics and methods of use thereof
AU7419396A (en) Clothespin and clothes-equipment
AU4236097A (en) Mhc peptides and methods of use
AU3118297A (en) Sok-1 and methods of use
PL331523A1 (en) Azolotrizines and azolopyrimidines
AU5218796A (en) Mailbox assembly and associated methods
GB9606882D0 (en) Signal and support structure
AU3826097A (en) Timing and scoring system
AU8561898A (en) Tone discrimination apparatus and tone discrimination diagram